Search

everythinglearnresearchcommunity

for

Search:↓

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Tamsulosin increases the risk of floppy iris syndrome during cataract surgery.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Finasteride effectively reduced priapism episodes in children with sickle cell disease without side effects.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Fibroblast Growth Factor-9 (FGF-9) can help improve heart function in diabetic mice after a heart attack by reducing inflammation and harmful changes to the heart's structure.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Spanlastic nano-vesicles improve famotidine's effectiveness and absorption.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Zinc sulfide cellulose scaffolds can reduce scarring and promote hair growth.

Fisetin may help treat psoriasis and reduce skin inflammation.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.